Sameer Kalghatgi

Title: **Innovator Spotlight: Sameer Kalghatgi**

Introduction

Sameer Kalghatgi is an accomplished inventor based in Waltham, MA (US). He holds a patent that contributes to advancements in the field of biomedical engineering, specifically related to enhancing growth factor release from cells and tissues. His innovative approach utilizes non-thermal plasma to promote endothelial cell proliferation, presenting promising implications for medical treatments.

Latest Patents

Sameer Kalghatgi’s notable patent is titled “Plasma treatment for growth factor release from cells and tissues.” The invention encompasses methods that involve contacting endothelial cells with non-thermal plasma to trigger the release of angiogenic growth factors. One significant aspect of this invention is the use of fibroblast growth factor-2, which plays a crucial role in promoting endothelial cell proliferation. Furthermore, the patent details methods for treating diseases either by promoting angiogenesis or by inhibiting it, thus showcasing the versatility of his approach.

Career Highlights

Kalghatgi is associated with Drexel University, where he contributes to research and innovation within the field of biomedical sciences. His academic involvement allows him to remain at the forefront of medical research, where he applies his expertise to develop novel therapeutic techniques based on his patent.

Collaborations

Throughout his career, Sameer Kalghatgi has collaborated with esteemed colleagues, including Alisa Morss Clyne and Gennady Friedman. These partnerships not only enhance the research dynamic but also foster the exchange of ideas that propel their shared projects toward impactful outcomes.

Conclusion

Sameer Kalghatgi exemplifies the spirit of innovation through his groundbreaking work in the biomedical field. His patent demonstrates a significant stride in using non-thermal plasma technologies to address critical health challenges. With his ongoing contributions at Drexel University and collaborations with fellow researchers, Kalghatgi continues to play a pivotal role in advancing medical science through innovative solutions.